Rheumatology International

, Volume 10, Issue 2, pp 47–49 | Cite as

A follow-up study of pulmonary function in patients with primary Sjögren's syndrome

  • M. Linstow
  • N. J. Kriegbaum
  • V. Backer
  • C. Ulrik
  • P. Oxholm
Originals

Summary

Twenty-seven patients (25 women, 2 men) with primary Sjögren's syndrome, previously reported to have reduced pulmonary diffusing capacities were reexamined in a 7-year follow-up in order to evaluate longitudinal alterations in pulmonary function. Primary Sjögren's syndrome was diagnosed according to the Copenhagen criteria. The present examination revealed normal and unchanged values for vital capacity, forced expiratory volume in 1 s, maximal expiratory flow at 50% of expired vital capacity (MEF50), and diffusing capacity per liter alveolar volume. Total diffusing capacity (P<0.01) and MEF75 (P<0.05), were, however, significantly reduced compared with the predicted values, indicating pulmonary involvement primarily affecting the small airways. The longitudinal examination, furthermore, showed increasing values for total diffusing capacity (P<0.02), diffusing capacity per liter alveolar volume (P<0.001), and MEF75 (P<0.02), suggesting an improvement in lung status in the course of time. No correlation was found between MEF75 and diffusing capacities, nor between alterations in pulmonary function and complaints of dyspnoea, tiredness, cough, expectoration, tobacco smoking, or medical treatment with bromhexine, glucocorticosteroids, essential fatty acids, or nonsteroid antiinflammatory drugs.

Key words

Primary Sjögren's syndrome Pulmonary diffusion capacity Maximal expiratory flow Pulmonary interstitial disease 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Oxholm P, Bundgard A, Madsen EB, Manthorpe R, Rasmussen FV (1982) Pulmonary involvement in patients with primary Sjögren's syndrome. Rheumatol Int 2: 179–181Google Scholar
  2. 2.
    Hunninghake GW, Fauci AS (1979) Pulmonary involvement in the collagen vascular diseases. Am Rev Resp Dis 119: 471–503Google Scholar
  3. 3.
    Strimlan CV, Rosenow EC, Divertie MB, Harrison EG Jr (1976) Pulmonary manifestations of Sjögren's syndrome. Chest 3: 354–361Google Scholar
  4. 4.
    Segal I, Fink G, Machtey I, Gura V, Spitzer SA (1981) Pulmonary function abnormalities in Sjögren's syndrome. Thorax 36: 286–289Google Scholar
  5. 5.
    Newball HH, Brahim SA (1977) Chronic obstructive airway disease in patients with Sjögren's syndrome. Am Rev Resp Dis 115: 295–304Google Scholar
  6. 6.
    Fairfax AJ, Haslam PL, Pavia D, Sheahan NF, Batemann JRM, Agnew JE, Clarke SW, Turner-Warwick M (1981) Pulmonary disorders associated with Sjögren's syndrome. Q J Med 50: 279–295Google Scholar
  7. 7.
    Deaver Collins R Jr, Ball GV, Logic JR (1984) Gallium-67 scanning in Sjögren's syndrome. J Nucl Med 25: 299–302Google Scholar
  8. 8.
    Bariffi F, Pesci A, Bertorelli G, Manganelli G, Umbanelli U (1984) Pulmonary involvement in Sjögren's syndrome. Respiration 46: 82–87Google Scholar
  9. 9.
    Constantopoulos SH, Droso AA, Maddison PJ, Moutsopoulos HM (1984) Xerotrachea and interstitial lung disease in primary Sjögren's syndrome. Respiration 46: 310–314Google Scholar
  10. 10.
    Vitalli C, Tavoni A, Viegi G, Begliomini E, Agnesi A, Bombardieri S (1985) Lung involvement in Sjögren's syndrome. Ann Rheum Dis 44: 455–461Google Scholar
  11. 11.
    Papathanasiou MP, Constantopoulos S, Tsampoulos C, Drosos AA, Moutsopoulos HM (1986) Reappraisal of respiratory abnormalities in primary and secondary Sjögren's syndrome. Chest 90: 370–375Google Scholar
  12. 12.
    Manthorpe R, Oxholm P, Prause JU, Schiødt M (1984/1986) the Copenhagen criteria for primary Sjögren's syndrome. Scand J Rheumatol [Suppl] 61: 19–21; 2: 77–106Google Scholar
  13. 13.
    Cotes JE (1979) Lung function, 4th edn. Blackwell, OxfordGoogle Scholar
  14. 14.
    Hatron P-Y, Wallaert B, Gosset D, Tonnel A-B, Gosselin B, Voisin B, Devulder B (1987) Subclinical lung inflammation in primary Sjögren's syndrome. Arthritis Rheum 11: 1226–1231Google Scholar
  15. 15.
    Hedgpeth MT, Boulware DW (1988) Pulmonary hypertension in primary Sjögren's syndrome. Ann Rheum Dis 47: 251–253Google Scholar
  16. 16.
    Muller K, Manthorpe R, Permin H, Høier-Madsen M, Oxholm P (in press) Circulating IgM rheumatoid factors in patients with primary Sjögren's syndrome. Scand J RheumatolGoogle Scholar
  17. 17.
    Prause PU, Kriegbaum NJ, Manthorpe R, Oxholm P (in press) Rose-Bengal score. A possible key parameter when evaluating disease level and progression in primary Sjögren's syndrome. J AutoimmunolGoogle Scholar
  18. 18.
    Kriegbaum NJ, Linstow M, Oxholm P, Prause JU (1988) Keratoconjunctivitis sicca in patients with primary Sjögren's syndrome. Acta Ophthalmol (Copenh) 66: 481–484Google Scholar

Copyright information

© Springer-Verlag 1990

Authors and Affiliations

  • M. Linstow
    • 1
  • N. J. Kriegbaum
    • 1
  • V. Backer
    • 1
  • C. Ulrik
    • 1
  • P. Oxholm
    • 1
  1. 1.Department of Rheumatology TTA and Laboratory for Respiratory Physiology, Medical Department BRigshospitalet, State University HospitalCopenhagen NDenmark

Personalised recommendations